InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Powl Brian T., Directeur Commercial. Director active across 2 companies, notably Fate Therapeutics INC. Aggregated, 10 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €108k. History available since 27 June 2022. The latest transaction was filed on 21 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Powl Brian T. is Directeur Commercial and Chief Commercial Officer at Kura Oncology, Inc. and Fate Therapeutics INC. Across 9 filings in total, the recently sampled filings cover the period from 2022-06-29 to 2026-01-27, with 0 in buys and 63712 in sells.